Pharma Mar SA
MAD:PHM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pharma Mar SA
MAD:PHM
|
ES |
|
C
|
CJ Corp
KRX:001045
|
KR |
|
J
|
Jefferson Capital Inc
NASDAQ:JCAP
|
US |
|
5N Plus Inc
F:EMB
|
CA |
|
CITIC Ltd
F:CPF0
|
CN |
|
C
|
Cahya Mata Sarawak Bhd
KLSE:CMSB
|
MY |
|
Cadence Design Systems Inc
NASDAQ:CDNS
|
US |
|
B
|
Brown & Brown Inc
XMUN:BTW
|
US |
|
S
|
Swiss Re AG
F:SR9A
|
CH |
|
A
|
AeroVironment Inc
F:JPX
|
US |
Intrinsic Value
Is PHM undervalued or overvalued?
See the intrinsic value estimate for Pharma Mar SA and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
PHM looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with PHM’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Pharma Mar Does
Pharma Mar is a Spanish biopharmaceutical company focused on cancer drugs. It discovers and develops medicines from marine organisms, then turns the best candidates into prescription treatments for hard-to-treat tumors. Its best-known products include oncology drugs sold directly or through partners in different markets.
- Headquarters
- Spain ES
- Employees
- 505
- IPO date
- Nov 2, 2015
Revenue & Expenses Breakdown
Pharma Mar SA
Earnings Waterfall
Pharma Mar SA
The intrinsic value for Pharma Mar SA (PHM) under the Base Case is hidden EUR.
Compared with the current market price of 70.8 EUR, the stock appears hidden.